PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2097157
PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2097157
According to Mordor Intelligence, the medical device cleaning market size was valued at USD 2.48 billion in 2025 and estimated to grow from USD 2.61 billion in 2026 to reach USD 3.36 billion by 2031, at a CAGR of 5.18% during the forecast period (2026-2031).

This report is Segmented by Product Type (Enzymatic Detergents, Non-Enzymatic Detergents and More), by Cleaning Process (Manual Cleaning, Automated Washer-Disinfectors and More), by Application (Surgical Instruments, Endoscopes and More), by End User (Hospitals, Ambulatory Surgical Centers and More) and Geography (North America and More). The Report Offers the Value (in USD) for the Above Segments.
HAIs add an estimated USD 25 billion-USD 45 billion to U.S. healthcare costs yearly. Although 2023 CDC data show double-digit declines in several device-associated infections, persistent bloodstream and endoscope-linked outbreaks have kept pressure on facilities to upgrade cleaning protocols. European surveillance recorded 7.1% HAI prevalence across 28 member states, equal to 4.3 million affected patients each year . Multidrug-resistant organisms such as carbapenem-resistant Klebsiella pneumoniae require extended contact times and multi-enzyme detergents that break down protective biofilms. This epidemiological environment is accelerating demand for validated chemistries and automated washer-disinfectors that deliver repeatable, trackable cycles.
The U.S. FDA now demands full cleaning validation data for high-risk reusable devices, including bronchoscopes and laparoscopic instruments. MDR 2017/745 classifies standalone cleaning systems as medical devices and mandates Unique Device Identification to guarantee traceability across the cleaning life-cycle. ISO 17664 requires manufacturers to describe exact detergent type, temperature and contact time, pushing hospitals toward branded chemistries aligned with device instructions. Automated systems that reduce operator variability have become the preferred route to regulatory confidence, particularly in high-volume surgical centers.
State-of-the-art washer-disinfectors cost USD 100,000-USD 300,000, while annual service contracts add 8%-12% of purchase price. Smaller hospitals and ASCs often struggle to justify this outlay, especially when staffing shortages already stretch operating budgets. Component inflation and freight surcharges have pushed supply-chain expenses close to 20% of revenue for many equipment makers, translating into higher list prices for buyers. As a workaround, vendors are rolling out subscription and leasing models that bundle chemistry, service and analytics in a per-cycle fee, but acceptance in price-sensitive markets remains limited.
Other drivers and restraints analyzed in the detailed report include:
For complete list of drivers and restraints, kindly check the Table Of Contents.
High-Level Disinfectants captured 37.10% of the medical device cleaning market in 2025 as they deliver proven sporicidal activity for semi-critical devices. Enzymatic Detergents, however, are forecast to record a 6.63% CAGR, the fastest within the category, because multi-enzyme blends dissolve protein, lipid and carbohydrate soils lodged in intricate lumens. Chlorine-dioxide formulations are also expanding due to broad-spectrum efficacy with lower material corrosion, while non-enzymatic detergents remain the low-cost staple for routine trays. Manufacturers are introducing pH-neutral blends that maintain potency across variable water quality, improving compatibility with delicate polymer-based instruments.
The medical device cleaning market size for Enzymatic Detergents is projected to advance steadily as facilities retire legacy alkaline agents that cannot break down resilient biofilms formed by carbapenem-resistant organisms. Uptake is particularly strong in ophthalmology, orthopedics and robotic surgery suites where instrument longevity is critical. User-friendly dosing pumps and color-changing test strips ensure correct concentration, reducing technician training burden. Despite ocular-procedure concerns over toxic anterior segment syndrome, recent peer-review findings indicate that thorough rinsing mitigates risk, supporting broader adoption in outpatient surgical centers.
Automated Washer-Disinfectors led the 2025 revenues with 40.85% share, reflecting industry confidence in repeatable thermal and chemical parameters. UV/Ozone/Emerging Technologies are expected to clock 7.42% CAGR as facilities seek low-temperature methods that sidestep ethylene oxide bottlenecks. Far-UVC 222 nm ceiling fixtures now operate continuously in occupied spaces, trimming downtime between cases. Plasma and vaporized-hydrogen-peroxide units are capturing demand for heat-sensitive plastics.
The medical device cleaning market size tied to automated platforms is expanding as internet-connected units verify each load against ISO 17664-specified cycles. Conversely, manual cleaning persists in low-resource environments but shows declining share as audit failures highlight variability risks. New ductless ethylene oxide scrubbers that achieve 99% destruction efficiency are reopening sterilization lines idled by emission limits, ensuring that washer-disinfectors remain the upstream workhorse.
The medical device cleaning market is moderately consolidated as strategic acquisitions reshape competitive dynamics. STERIS, Getinge and Ecolab remain the reference suppliers due to broad portfolios spanning chemistries, washer-disinfectors and service contracts. Medline's USD 950 million purchase of Ecolab's surgical solutions business in 2024 instantly broadened its consumables range and expanded access to European operating rooms. Thermo Fisher's USD 4.1 billion acquisition of Solventum's purification and filtration division in 2025 extends its reach into validated chemistries and membrane-based cleaning adjuncts.
Competition centers on automation, sensor integration and regulatory documentation. Getinge is rolling out vision-guided loading robots that cut operator touches by 30%, while Tristel leverages chlorine-dioxide chemistry registered in 38 countries to offer wipe-based high-level disinfection for niche scopes. Smaller innovators such as Sonata Scientific target emission-control niches with ductless EtO destruction units, easing pressure on sterilization capacity. Because no single customer accounts for more than 10% of STERIS revenue, demand remains fragmented and open to specialized entrants that address robotic instruments, ophthalmic scopes or plasma sterilization accessories.
Price competition is limited at the premium end, but mid-tier Asian suppliers are moving up-market with washer-disinfectors featuring basic IoT dashboards. Global service footprints, rapid part availability and operator training packages therefore differentiate incumbents. Partnerships between detergent formulators and equipment OEMs are tightening as hospitals prefer one-stop procurement that simplifies validation paperwork and warranty liability.